Evidence map›Paper›PMID 27412706›Full record

Trial reportEuropean journal of nutrition2017

Probiotics modulate gut microbiota and health status in Japanese cedar pollinosis patients during the pollen season.

Gaku Harata, Himanshu Kumar, Fang He, Kenji Miyazawa, Kazutoyo Yoda, Manabu Kawase, Akira Kubota, Masaru Hiramatsu, Samuli Rautava, Seppo Salminen

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in European journal of nutrition, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Novel probiotic preparation withMicrobiology spectrum · 2024
    Trial
  5. Trial
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Probiotics: The Next Dietary Strategy against Brain Aging.Preventive nutrition and food science · 2022
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Microbiome characteristics andTranslational cancer research · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Gaku HarataTechnical Research Laboratory, Takanashi Milk Products Co., Ltd., Yokohama, 241-0023, Japan. g-harata@takanashi-milk.co.jp.
Himanshu KumarFunctional Foods Forum, University of Turku, 20014, Turku, Finland.
Fang HeTechnical Research Laboratory, Takanashi Milk Products Co., Ltd., Yokohama, 241-0023, Japan. ka-hou@takanashi-milk.co.jp.
Kenji MiyazawaTechnical Research Laboratory, Takanashi Milk Products Co., Ltd., Yokohama, 241-0023, Japan.
Kazutoyo YodaTechnical Research Laboratory, Takanashi Milk Products Co., Ltd., Yokohama, 241-0023, Japan.
Manabu KawaseTechnical Research Laboratory, Takanashi Milk Products Co., Ltd., Yokohama, 241-0023, Japan.
Akira KubotaTechnical Research Laboratory, Takanashi Milk Products Co., Ltd., Yokohama, 241-0023, Japan.
Masaru HiramatsuTechnical Research Laboratory, Takanashi Milk Products Co., Ltd., Yokohama, 241-0023, Japan.
Samuli RautavaFunctional Foods Forum, University of Turku, 20014, Turku, Finland.
Seppo SalminenFunctional Foods Forum, University of Turku, 20014, Turku, Finland.
Megmilk Snow Brand (Japan) · JPUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundJapanese cedar pollinosis (JCP) is a challenging public health problem in Japan. Altered gut microbiota is associated with several diseases, including allergic diseases. However, only a few studies have focused on JCP and the underlying mechanisms for probiotic effects remain unclear. In addition, this study is the first observation of the correlation between the gut microbiota and blood lipid in JCP.

methodsFaecal samples from JCP subjects were collected before and after treatment with (n = 14) and without (n = 11) LGG-TMC0356-fermented milk for 10 weeks. Gut microbiota composition was characterized from faecal DNA using sequencing of 16S rRNA genes.

results16S rRNA-based operational taxonomic unit clustering of the microbiota revealed that LGG-TMC0356-fermented milk significantly altered gut microbiota after 10 weeks of milk consumption, and eight dominant genera of microbes were detected. During the JCP season, the Bacteroidetes/Firmicutes ratio, when compared to baseline, was significantly decreased in subjects at end of the study. Bacteroidetes showed positive correlation with LDL- and HDL-cholesterol levels, whereas Firmicutes showed negative correlation with total cholesterol, LDL- and HDL- cholesterol.

conclusionsThe altered gut microbiota through supplementation of fermented milk containing the study probiotics may be a prospective target for protection against JCP, with beneficial effects on blood lipid levels.

Indexed as

Gastrointestinal MicrobiomeAdultBacillotaBacteroidetesCholesterolCreatinineCryptomeriaCultured Milk ProductsDietDouble-Blind MethodFecesFemaleHumansImmunoglobulin EJapanLacticaseibacillus rhamnosusCholesterolCreatinineImmunoglobulin ETriglyceridesAllergyBlood lipidGut microbiotaJCPLactobacillus gasseri TMC0356Lactobacillus rhamnosus GGProbiotic

Identifiers

PMID27412706
OpenAlexW2469517604

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.